Latest Shareholder Equity News

Advanced Health Intelligence Ltd (AHI) reports robust commercial progress and strategic funding moves in Q1 2025 despite ongoing ASX trading suspension and recent NASDAQ delisting. Key partnerships and technology validations position the company for a strong global scale-up.

Supply Network Limited has announced a fully franked ordinary dividend of AUD 0.38 per share for the fiscal year ending June 2025, accompanied by a Dividend Reinvestment Plan offering a 2.5% discount on new shares.

Strike Resources signals potential for an additional A$5 million capital raise through oversubscriptions, pending board approval, with new shares under Tranche 2 set to follow the Share Purchase Plan issuance.

Zelira Therapeutics has locked in a $650,000 loan facility secured against its anticipated FY25 R&D tax rebate, aiming to accelerate its HOPE SPV clinical trial and strengthen working capital.

Accelerate Resources has kicked off its maiden drilling campaign at the Kanowna Gold East Project, refining targets through advanced gravity surveys, while bolstering its cash reserves with a $2 million non-dilutive injection.

Pacific Edge Limited has opened a $5 million Share Purchase Plan at $0.10 per share, conditional on shareholder approval of a prior $16.1 million Placement. The capital raise aims to extend the company’s cash runway and accelerate US market adoption of its bladder cancer diagnostic tests amid Medicare non-coverage.

Advanced Health Intelligence has been formally delisted from NASDAQ due to shareholder equity deficiencies but is actively pursuing ASX reinstatement as a critical step toward regaining its dual-listing status.

Imperial Pacific reports a solid 14.4% increase in net worth for FY2025, driven by strong investment gains and strategic moves including reinstating its Dividend Reinvestment Plan.

Rhythm Biosciences has obtained a $1 million non-dilutive loan backed by its FY2025 R&D Tax Incentive rebate, aiming to accelerate the commercial rollout of its ColoSTAT® test and expand its geneType™ platform.

Vinyl Group has secured a $1.5 million revolving credit facility from Songtradr and proposed converting historical liabilities into equity, aiming to boost its balance sheet and accelerate growth on its Vinyl.com platform.

I Synergy Group Limited has successfully raised approximately $1 million through a fully underwritten entitlement offer, with robust shareholder participation and full underwriting support.

Opyl Limited has taken a bold step into digital assets by acquiring approximately 2 Bitcoin and securing a $2 million finance facility backed by these holdings, signaling a strategic pivot towards blockchain integration in healthcare technology.